Harbor Investment Advisory’s SPDR S&P Biotech ETF XBI Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $49.8K | Sell |
600
-560
| -48% | -$46.4K | ﹤0.01% | 637 |
|
|
2025
Q1 | $94.1K | Sell |
1,160
-4,285
| -79% | -$348K | 0.01% | 485 |
|
|
2024
Q4 | $490K | Sell |
5,445
-1,666
| -23% | -$150K | 0.05% | 238 |
|
|
2024
Q3 | $703K | Buy |
7,111
+64
| +0.9% | +$6.32K | 0.07% | 199 |
|
|
2024
Q2 | $653K | Sell |
7,047
-2,250
| -24% | -$209K | 0.07% | 197 |
|
|
2024
Q1 | $882K | Buy |
9,297
+6,999
| +305% | +$664K | 0.09% | 167 |
|
|
2023
Q4 | $205K | Buy |
2,298
+938
| +69% | +$83.8K | 0.02% | 323 |
|
|
2023
Q3 | $99.3K | Sell |
1,360
-1,730
| -56% | -$126K | 0.01% | 398 |
|
|
2023
Q2 | $257K | Sell |
3,090
-430
| -12% | -$35.8K | 0.04% | 304 |
|
|
2023
Q1 | $268K | Sell |
3,520
-290
| -8% | -$22.1K | 0.04% | 299 |
|
|
2022
Q4 | $316K | Sell |
3,810
-1,600
| -30% | -$133K | 0.05% | 272 |
|
|
2022
Q3 | $429K | Buy |
5,410
+1,260
| +30% | +$99.9K | 0.07% | 216 |
|
|
2022
Q2 | $308K | Buy |
4,150
+800
| +24% | +$59.4K | 0.05% | 262 |
|
|
2022
Q1 | $301K | Sell |
3,350
-50
| -1% | -$4.49K | 0.04% | 288 |
|
|
2021
Q4 | $381K | Buy |
3,400
+1,580
| +87% | +$177K | 0.05% | 255 |
|
|
2021
Q3 | $229K | Hold |
1,820
| – | – | 0.03% | 338 |
|
|
2021
Q2 | $246K | Sell |
1,820
-50
| -3% | -$6.76K | 0.03% | 329 |
|
|
2021
Q1 | $254K | Buy |
1,870
+60
| +3% | +$8.15K | 0.04% | 295 |
|
|
2020
Q4 | $255K | Buy |
1,810
+400
| +28% | +$56.4K | 0.04% | 268 |
|
|
2020
Q3 | $157K | Buy |
1,410
+400
| +40% | +$44.5K | 0.03% | 305 |
|
|
2020
Q2 | $113K | Buy |
+1,010
| New | +$113K | 0.02% | 333 |
|
|
2020
Q1 | – | Sell |
-50
| Closed | -$5K | – | 1201 |
|
|
2019
Q4 | $5K | Buy |
+50
| New | +$5K | ﹤0.01% | 711 |
|